Related Experiment Video
Updated: Jul 21, 2025

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
Published on: September 9, 2022
Ferroptosis induces detrimental effects in chronic EAE and its implications for progressive MS
Priya Jhelum1, Stephanie Zandee2,3, Fari Ryan1
1Centre for Research in Neuroscience and BRaIN Program, Research Institute of the McGill University Health Centre (RI-MUHC), Livingston Hall, Room L7-210, 1650 Cedar Ave., Montreal, QC, H3G 1A4, Canada.
Abstract:
Ferroptosis is a form of lipid peroxidation-mediated cell death and damage triggered by excess iron and insufficiency in the glutathione antioxidant pathway. Oxidative stress is thought to play a crucial role in progressive forms of multiple sclerosis (MS) in which iron deposition occurs. In this study we assessed if ferroptosis plays a role in a chronic form of experimental autoimmune encephalomyelitis (CH-EAE), a mouse model used to study MS. Changes were detected in the mRNA levels of several ferroptosis genes in CH-EAE but not in relapsing-remitting EAE. At the protein level, expression of iron importers is increased in the earlier stages of CH-EAE (onset and peak). While expression of hemoxygenase-1, which mobilizes iron from heme, likely from phagocytosed material, is increased in macrophages at the peak and progressive stages. Excess iron in cells is stored safely in ferritin, which increases with disease progression. Harmful, redox active iron is released from ferritin when shuttled to autophagosomes by 'nuclear receptor coactivator 4' (NCOA4). NCOA4 expression increases at the peak and progressive stages of CH-EAE and accompanied by increase in redox active ferrous iron. These changes occur in parallel with reduction in the antioxidant pathway (system xCT, glutathione peroxidase 4 and glutathione), and accompanied by increased lipid peroxidation. Mice treated with a ferroptosis inhibitor for 2 weeks starting at the peak of CH-EAE paralysis, show significant improvements in function and pathology. Autopsy samples of tissue sections of secondary progressive MS (SPMS) showed NCOA4 expression in macrophages and oligodendrocytes along the rim of mixed active/inactive lesions, where ferritin+ and iron containing cells are located. Cells expressing NCOA4 express less ferritin, suggesting ferritin degradation and release of redox active iron, as indicated by increased lipid peroxidation. These data suggest that ferroptosis is likely to contribute to pathogenesis in CH-EAE and SPMS.
Insights
Ferroptosis, a cell death pathway involving iron and lipid peroxidation, is implicated in chronic experimental autoimmune encephalomyelitis (CH-EAE) and secondary progressive multiple sclerosis (SPMS). Inhibiting ferroptosis improved CH-EAE outcomes, suggesting its therapeutic potential.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Ferroptosis is a regulated cell death pathway driven by iron-dependent lipid peroxidation.
- Oxidative stress and iron deposition are implicated in progressive multiple sclerosis (MS).
- Experimental autoimmune encephalomyelitis (EAE) models are used to study MS pathogenesis.
Purpose of the Study:
- To investigate the role of ferroptosis in chronic EAE (CH-EAE), a mouse model for MS.
- To examine ferroptosis markers and therapeutic interventions in CH-EAE and human SPMS.
Main Methods:
- Assessed mRNA and protein levels of ferroptosis-related genes and proteins in CH-EAE.
- Analyzed iron metabolism markers, antioxidant pathways, and lipid peroxidation.
- Treated CH-EAE mice with a ferroptosis inhibitor.
- Examined autopsy tissue from SPMS patients.
Main Results:
- CH-EAE showed altered ferroptosis gene expression and increased iron importers, heme oxygenase-1, and ferritin.
- Nuclear receptor coactivator 4 (NCOA4) expression increased, correlating with redox-active iron and lipid peroxidation.
- Antioxidant pathways were reduced in CH-EAE.
- Ferroptosis inhibition improved CH-EAE function and pathology.
- SPMS tissues showed NCOA4 expression in macrophages and oligodendrocytes near iron-laden cells.
Conclusions:
- Ferroptosis plays a significant role in the pathogenesis of CH-EAE.
- NCOA4-mediated ferritinophagy contributes to iron release and ferroptosis in CH-EAE and SPMS.
- Targeting ferroptosis may offer a therapeutic strategy for progressive MS.
More Related Videos
05:44Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
Published on: October 13, 2023
09:20Implanting Glass Spinal Cord Windows in Adult Mice with Experimental Autoimmune Encephalomyelitis
Published on: December 21, 2013